Acquiring funding for such research is a challenge—the stigmatization of psilocybin has prompted governmental funding bodies to avoid initiatives involving the compound. However, Nichols thinks that, as trials demonstrating the prospective benefits of psilocybin keep popping out, there might be a larger drive and incentive for investment. “There ought to https://knoxtwvr899988.blog2news.com/31226125/everything-about-benefits-of-copyright-mushrooms